News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement

Stephen Casey

Advertisement

Articles by Stephen Casey

Stephen Casey

From Science to Sales: Leveraging Medical Affairs for Commercial Triumph

ByStephen Casey
April 15th 2025

Marketing and sales personnel who leverage the expertise and insights of MedAffairs can often have better success.

Advertisement

Latest Updated Articles

  • Stephen Casey
    From Science to Sales: Leveraging Medical Affairs for Commercial Triumph

    Published: April 15th 2025 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma

2

The Situation We Faced: The Development and Commercialization of MariTide

3

Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform

4

Novo Nordisk Enters $4.7 Billion Definitive Agreement with Akero Therapeutics

5

Pharmaceutical Executive Daily: Amgen Launches New Direct-To-Consumer Platform

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us